Skip to Page Content
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.



Dr. Garvey will discuss the role of anorectic medications in long-term treatment, existing evidence for their long-term safety, long-term disease improvement or remission, and prevention of disease relapse.

Presentation Information
Presentation Date:
October 30, 2017
Expiration Date:
December 31, 2020 11:55 PM
Presentation Objectives
  • Prescribe anti-obesity medications for long-term treatment of obesity, understanding fully the evidence for efficacy, safety, and risks.
The Long-term Use of Anorectic Medications

(Speaker biography at time of recording)


Dr. Garvey is a professor of medicine and the chairman of the Department of Nutrition Sciences at the University of Alabama at Birmingham (UAB). He has achieved international recognition for his research on metabolic, molecular, and genetic pathogenesis of insulin resistance; type 2 diabetes; and obesity. He has directed an independent laboratory since 1987, which is supported by a number of national health organizations. He has served as the principal investigator of the UAB Diabetes Research Center since its initiation in 2008.

Individual topic purchase: Selected
Share This
Preview The Long-term Use of Anorectic MedicationsPreview The Long-term Use of Anorectic Medications
All Access Subscription
Use for All Access  account holders only
To continue, you need to log in to oma. If you have any questions about your account please contact us at 1-866-702-3278.
Email Address:
OMA Member Price: